Expression of fas antigen (CD95) in peripheral blood lymphocytes and in liver-infiltrating, cytotoxic lymphocytes in patients with hepatocellular carcinoma

Cancer

Volumn 92, Issue 8, 2001, Pages 2136-2141

  Yuen, Man Fung ^a,b   Hughes, Robin D ^a   Heneghan, Michael A ^b   Langley, Peter G ^b   Norris, Suzanne ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Flow cytometry; Natural killer cell; Natural T cell; Transforming growth factor ; Tumor infiltrating lymphocytes

Indexed keywords

FAS ANTIGEN; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; MALE; NATURAL KILLER CELL; PRIORITY JOURNAL; TUMOR ASSOCIATED LEUKOCYTE; TUMOR VOLUME;

ADULT; AGED; ANTIGENS, CD95; CARCINOMA, HEPATOCELLULAR; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; FLOW CYTOMETRY; HUMANS; KILLER CELLS, NATURAL; LIVER NEOPLASMS; MALE; MIDDLE AGED; STATISTICS, NONPARAMETRIC; T-LYMPHOCYTES, CYTOTOXIC; TRANSFORMING GROWTH FACTOR BETA;

EID: 0035886635     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0142(20011015)92:8<2136::AID-CNCR1555>3.0.CO;2-J     Document Type: Article

References (27)

1. Why do defects in the Fas-Fas ligand system cause autoimmunity?
2. The Fas counterattack in vivo: Apoptotic depletion of tumor-infiltrating lymphocytes associated with Fas ligand expression by human esophageal carcinoma
3. The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand
4. Fas antigen expression in hepatocellular carcinoma tissues
5. Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells - A mechanism of immune evasion
6. Resident human hepatic lymphocytes are phenotypically different from circulating lymphocytes
7. Natural T cells in the human liver: Cytotoxic lymphocytes with dual T cell and natural killer cell phenotype and function are phenotypically heterogeneous and include Vα24-JαQ and γδ T cell receptor bearing cells
8. The human liver contains multiple populations of NK cells, T cells, and CD3+CD56+ natural T cells with distinct cytotoxic activities and Th1, Th2, and Th0 cytokine secretion patterns
9. Effects of transforming growth factor-beta on human lymphokine-activated killer cell precursors. Autocrine inhibition of cellular proliferation and differentiation to immune killer cells
10. Regulation of immune responses by TGF-beta
11. Transforming growth factor-beta inhibits the generation of cytotoxic T cells in virus-infected mice
12. Immunosuppression and transforming growth factor-beta in glioblastoma. Preferential production of transforming growth factor-beta 2
13. Regulation of lymphokine-activated killer activity and poreforming protein gene expression in human peripheral blood CD8+ T lymphocytes. Inhibition by transforming growth factor-beta
14. Transforming growth factor beta 1 inhibits Fas ligand expression and subsequent activation-induced cell death in T cells via downregulation of c-Myc
15. Transforming growth factor-beta-induced expression of CD94/NKG2A inhibitory receptors in human T lymphocytes
16. Regulation of KIR expression in human T cells: A safety mechanism that may impair protective T-cell responses
17. Elevated levels of transforming growth factor beta messenger RNA and its polypeptide in human hepatocellular carcinoma
18. The host-tumor immune conflict: From immunosuppression to resistance and destruction
19. In situ investigation of Fas/FasL expression in chronic hepatitis B infection and related liver diseases
20. Fas system and apoptosis in viral hepatitis
21. Plasma transforming growth factor-beta 1 concentrations in patients with chronic viral hepatitis
22. Growth kinetic study of human hepatocellular carcinoma using proliferating cell nuclear antigen and Lewis Y antigen: Their correlation with transforming growth factoralpha and beta 1
23. Transforming growth factor-beta 1 abrogates Fas-induced growth suppression and apoptosis of murine bone marrow progenitor cells
24. TGF-beta 1 promotes in vitro generation of dendritic cells by protecting progenitor cells from apoptosis
25. CD4 T cells and their role in antitumor immune responses
26. The central role of CD4(+) T cells in the antitumor immune response
27. A model for CD8+ CTL tumor immunosurveillance and regulation of tumor escape by CD4 T cells through an effect on quality of CTL